Guangzhou Wondfo Biotech Co Ltd (300482):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Wondfo Biotech Co Ltd (300482) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8083
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also offers fertility tests, drug of abuse tests, POCT detection equipment, cardiovascular products, diabetes products and tumor products. The company’s fertility tests comprise LH midstream, LH card, HCG midstream, one step HCG urine pregancy test card, LH strip and HCG strip.. The company offers OEM service for its customers. It has operation in the China and the US. Wondfo is headquartered in Guangzhou, China.

Guangzhou Wondfo Biotech Co Ltd (300482) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Wondfo Biotech Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Guangzhou Wondfo Biotech to Form Joint Venture in Shandong 10
Acquisition 11
Guangzhou Wondfo Biotech Plans to Acquire Additional 31% Stake in Beijing-Based Biomedical Tech Company 11
Guangzhou Wondfo Biotech Plans to Acquire Additional 9.7% Stake in Suzhou-Based Bio-Tech Company 12
Guangzhou Wondfo Biotech Co Ltd – Key Competitors 13
Guangzhou Wondfo Biotech Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Wondfo Biotech Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Wondfo Biotech to Form Joint Venture in Shandong 10
Guangzhou Wondfo Biotech Plans to Acquire Additional 31% Stake in Beijing-Based Biomedical Tech Company 11
Guangzhou Wondfo Biotech Plans to Acquire Additional 9.7% Stake in Suzhou-Based Bio-Tech Company 12
Guangzhou Wondfo Biotech Co Ltd, Key Competitors 13
Guangzhou Wondfo Biotech Co Ltd, Subsidiaries 14

List of Figures
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangzhou Wondfo Biotech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Wondfo Biotech Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Wondfo Biotech Co Ltd (300482):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CCP Technologies Ltd (CT1):医療機器:M&Aディール及び事業提携情報
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd, is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware …
  • Brooks Automation Inc (BRKS):企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • PT. Indonesia Power:発電所・企業SWOT分析
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • China XD Plastics Co Ltd (CXDC):企業の財務・戦略的SWOT分析
    China XD Plastics Co Ltd (CXDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Homeland Energy Solutions, LLC:企業の戦略的SWOT分析
    Homeland Energy Solutions, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Accelya Kale Solutions Limited (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Kale Solutions Limited (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Altacor Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products comprise liquid gel, eye drop, eye mask, eyelid cleaner, nutritional supplement, and others. Altaco …
  • ConSynance Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics) is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company’s pipeline programs include CSTI-100, CSTI-200, and CSTI-300 among others. It develops pipeline programs fo …
  • Inframark LLC:企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Naia Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Naia Ltd (Naia) is a drug development company that funds and develops biotechnology companies addressing regional and global medical needs. The company develops and manufactures therapeutics for metabolic and rare diseases. It provides global drug development through funding, clinical develo …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務分析
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Wipro Ltd:戦略・SWOT・企業財務分析
    Wipro Ltd - Strategy, SWOT and Corporate Finance Report Summary Wipro Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Teleflex Incorporated:戦略・SWOT・企業財務分析
    Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • JA Solar Holdings Co Ltd (JASO):電力:M&Aディール及び事業提携情報
    Summary JA Solar Holdings Co Ltd (JA Solar) is a developer and provider of solar photovoltaic products. The company designs, develops, manufactures and sells silicon wafers, solar cells and solar modules. It offers both monocrystalline and mulicrystalline solar cells and modules. JA Solar also provi …
  • Apogenix AG-製薬・医療分野:企業M&A・提携分析
    Summary Apogenix AG (Apogenix) is a biopharmaceutical company, developing immuno-oncology medicines for the treatment of cancer and other malignant diseases. Its pipeline drug candidates under clinical development include Asunercept (APG101), a CD95 ligand inhibitor, for the treatment of glioblastom …
  • Solidarity Bahrain B.S.C.:企業の戦略・SWOT・財務情報
    Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report Summary Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆